Stem cell biotech: seeking a piece of the action.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18295564.
- Also identified by DOI 10.1016/j.cell.2008.02.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Venture capital groups and big pharma have largely held back from investing in biotech companies focused on regenerative medicine. Will it take a clinical bull's eye to bring venture capitalists and big pharma into the cell therapy arena?
Medical subject headings
- Biomedical Research
- Biomedical Technology
- Stem Cells